PIA
PRAH

Piedmont Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Piedmont Investment Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,296
Closed -$855K – 776
2020
Q1 		$855K Buy
10,296
+892
+9% +$87K 0.03% 328
2019
Q4 		$1.04M Sell
9,404
-826
-8% -$85K 0.04% 328
2019
Q3 		$1.01M Buy
10,230
+238
+2% +$23.6K 0.04% 312
2019
Q2 		$991K Buy
9,992
+4,180
+72% +$399K 0.04% 331
2019
Q1 		$641K Buy
5,812
+76
+1% +$7.94K 0.03% 428
2018
Q4 		$527K Buy
5,736
+1,609
+39% +$163K 0.03% 444
2018
Q3 		$455K Buy
+4,127
New +$430K 0.02% 573

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Piedmont Investment Advisors's PRAH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 10,296 shares — an estimated $855K sold.

Piedmont Investment Advisors first reported a position in PRAH in Q3 2018 and held it in 7 quarters. The position peaked at $1.04M in Q4 2019. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 10,296 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $855K.
  • Piedmont Investment Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 7 quarters.
  • Piedmont Investment Advisors's PRA Health Sciences, Inc. position peaked at $1.04M in Q4 2019.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.